Investors Seek Fees While Altor-NantCell Deal Suit Goes On
Altor Bioscience Corp. shareholders challenging the merger with billionaire physician Patrick Soon-Shiong's NantCell Inc., purportedly valued at nearly $300 million, pushed the Delaware Chancery Court on Wednesday for a mootness fee...To view the full article, register now.
Already a subscriber? Click here to view full article